Review
Copyright ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. May 21, 2016; 22(19): 4651-4661
Published online May 21, 2016. doi: 10.3748/wjg.v22.i19.4651
Auto immune hepatitis
Nicole MF van Gerven, Ynto S de Boer, Chris JJ Mulder, Carin MJ van Nieuwkerk, Gerd Bouma
Nicole MF van Gerven, Ynto S de Boer, Chris JJ Mulder, Carin MJ van Nieuwkerk, Gerd Bouma, Department of Gastroenterology and Hepatology, Vu University Medical Centre, 1081 HV, Amsterdam, The Netherlands
Author contributions: van Gerven NMF wrote the paper; de Boer YS designed the paper; Mulder CJJ supervised the paper; van Nieuwkerk CMJ supervised the paper; Bouma G supervised the paper; all authors critically read and approved the final manuscript.
Conflict-of-interest statement: All authors declare that they have no competing interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Chris JJ Mulder, Professor, Department of Gastroenterology and Hepatology, Vu University Medical Centre, De Boelelaan 1118, 1081 HV Amsterdam, The Netherlands. cjmulder@vumc.nl
Telephone: +31-20-4440613 Fax: +31-20-4449406
Received: February 27, 2016
Peer-review started: February 28, 2016
First decision: March 21, 2016
Revised: March 29, 2016
Accepted: April 20, 2016
Article in press: April 20, 2016
Published online: May 21, 2016
Core Tip

Core tip: Autoimmune hepatitis (AIH) is a chronic inflammatory liver disorder of unknown aetiology, which can lead to hepatic failure and premature death when untreated. In AIH there is no existence of a pathognomonic feature and therefore the diagnosis rests on a combination of immunological, biochemical, and histological features together with exclusion of other liver diseases. Due to large heterogeneity of the disease, AIH might be unrecognised. Immunosuppressive treatment has been the cornerstone of treatment. Such treatment is often successful at inducing remission. For most patients life long treatment is indicated. In patients in whom all treatments fail, liver transplantation remains a final option.